BIOSPECIFICS TECHNOLOGIES CORP Operating Lease, Expense
BIOSPECIFICS TECHNOLOGIES CORP reported Operating Lease, Expense of $21.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-11-09
- BIOSPECIFICS TECHNOLOGIES CORP operating lease, expense for the quarter ending 2020-09-30 was $21.00K, a 38.24% decline year-over-year.
- BIOSPECIFICS TECHNOLOGIES CORP operating lease, expense for the quarter ending 2020-06-30 was $23.00K, a 32.35% decline year-over-year.
- BIOSPECIFICS TECHNOLOGIES CORP operating lease, expense for the quarter ending 2019-09-30 was $34.00K.
- BIOSPECIFICS TECHNOLOGIES CORP operating lease, expense for the quarter ending 2019-06-30 was $34.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month |
|---|---|---|---|
| 2020-09-30 | $21.00K 10-Q · filed 2020-11-09 | $44.00K derived: sum of 2 quarters · filed 2020-11-09 | $101.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $23.00K 10-Q · filed 2020-08-10 | $80.00K 10-Q · filed 2020-08-10 | |
| 2019-09-30 | $34.00K 10-Q · filed 2020-11-09 | $68.00K derived: sum of 2 quarters · filed 2020-11-09 | $101.00K 10-Q · filed 2020-11-09 |
| 2019-06-30 | $34.00K 10-Q · filed 2020-08-10 | $67.00K 10-Q · filed 2020-08-10 |